---
title: "MUC1"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "## Gene: MUC1"
tags: ['MUC1', 'TransmembraneProtein', 'CellSignaling', 'Cancer', 'AutoimmuneDisorders', 'TargetedTherapy', 'Chemotherapy', 'Immunotherapy']
---

## Gene: MUC1

### Genetic Position and Aliases
- **Genomic Location**: Chromosome 1 (NC_000001.11)
- **Gene ID**: 4582 
- **Aliases**: EMA, MCD, PEM, PUM, KL-6, CD227, MUC-1/SEC, CA15-3, MAM6, MCKD, MUC-1

### Function for gene
MUC1 is a transmembrane protein that plays a crucial role in cell signaling and adhesion. It is highly expressed in various epithelial tissues, including mammary gland, lung, and gastrointestinal tract. MUC1 interacts with different ligands and receptors, such as galectin-3, ErbB2/HER2, and EGFR, to modulate various cellular processes, including cell proliferation, differentiation, apoptosis, and invasion.

### External IDs for gene
- **HGNC**: 7508
- **NCBI Entrez**: 4582
- **Ensembl**: ENSG00000115414
- **OMIM**: 158340
- **UniProtKB/Swiss-Prot**: P15941

### AA mutation list and mutation type with dbSNP ID
- c.347C>T (p.Pro116Leu) rs1800644
- c.1154G>A (p.Val385Ile) rs2070803

### Somatic SNVs/InDels with dbSNP ID
- c.5681G>A (p.Arg1894Gln) rs148799315

### Related Disease
MUC1 has been reported to be involved in various diseases, including cancer and autoimmune disorders. In cancer, MUC1 is aberrantly expressed and contributes to tumor development and progression by modulating various signaling pathways. In autoimmune disorders, MUC1 is involved in the pathogenesis of Sj√∂gren's syndrome, Crohn's disease, and rheumatoid arthritis by inducing autoantibody production.

### Treatment and Prognosis
As MUC1 is involved in the development and progression of cancer, it is a potential target for cancer therapy. Various strategies have been developed to target MUC1, including monoclonal antibodies, vaccines, and small molecules. However, the clinical efficacy of MUC1-targeted therapy is still limited, and more research is needed to develop effective treatments.

### Drug Response
There is evidence that MUC1-targeted therapy can enhance the efficacy of chemotherapy and immunotherapy in cancer. For example, a clinical trial of an anti-MUC1 vaccine in breast cancer patients showed that the vaccine improved the response to chemotherapy and increased survival.

### Related Papers
- Beatson R, Tajadura-Ortega V, Achkova D, et al. The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9. Nat Immunol. 2016;17(11):1273-1281. doi:10.1038/ni.3552
- Holdenrieder S, Stieber P. Clinical use of MUC1 and other tumor-associated antigens in cancer patients. Expert Rev Mol Diagn. 2011;11(6):671-684. doi:10.1586/erm.11.42
- Raina D, Ahmad R, Joshi MD, et al. Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells. Cancer Res. 2009;69(12):5133-5141. doi:10.1158/0008-5472.CAN-08-4638

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**